Literature DB >> 10648079

Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma.

T Ishida1.   

Abstract

The CD44 variant 6 (CD44 v6) has been postulated to be involved in both carcinogenesis and tumor progression. In the present study, CD44 v6 was stained immunohistochemically in 63 colorectal cancer tissues to assess significance of CD44 v6 in the carcinogenesis and progression of colorectal carcinoma. None of the normal colonocytes showed an expression of CD44 v6. CD44 v6 expression was very strong in 24, moderate in 13, and negative in 26 tumor tissues. A negative or moderate expression of CD44 v6 was significantly associated with a larger tumor size (P < 0.05) and invasion through the bowel wall (P < 0.01). There was no correlation between the expression of CD44 v6 and gross type, histologic differentiation, lymph node involvement, liver metastasis, and clinical stage of the disease. The present study showed that the expression of CD44 v6 was characteristic of neoplastic changes in the colonocytes and that a diminished expression of CD44 v6 was associated with the penetration of colorectal cancer through the bowel wall, but not with either lymph node or distant metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648079     DOI: 10.1007/PL00010042

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Relationship between the expression of CD44v6 and development, progress, invasion and metastasis of laryngeal carcinoma.

Authors:  Banghua Liu; Weijia Kong; Shusheng Gong; Chengzhang Yang; Guangping Wang; Lixin Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers.

Authors:  Jun-Jie Peng; San-Jun Cai; Hong-Feng Lu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Ming-He Wang; Ye Xu
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

Review 3.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

Review 4.  CD44 and HCELL: preventing hematogenous metastasis at step 1.

Authors:  Pieter P Jacobs; Robert Sackstein
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

5.  Impact of structurally modifying hyaluronic acid on CD44 interaction.

Authors:  D Bhattacharya; D Svechkarev; J J Souchek; T K Hill; M A Taylor; A Natarajan; A M Mohs
Journal:  J Mater Chem B       Date:  2017-09-20       Impact factor: 6.331

6.  Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.

Authors:  Yong-Jun Liu; Pei-Song Yan; Jun Li; Jing-Fen Jia
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

7.  Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Authors:  Shibnath Ghatak; Galina S Bogatkevich; Ilia Atnelishvili; Tanjina Akter; Carol Feghali-Bostwick; Stanley Hoffman; Victor M Fresco; John C Fuchs; Richard P Visconti; Roger R Markwald; Subhas B Padhye; Richard M Silver; Vincent C Hascall; Suniti Misra
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

8.  Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.

Authors:  Suvi Tuulia Avoranta; Eija Annika Korkeila; Kari Juhani Syrjänen; Seppo Olavi Pyrhönen; Jari Toivo Tapio Sundström
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

9.  Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis.

Authors:  Martin Köbel; Wilko Weichert; Katharina Crüwell; Wolfgang D Schmitt; Christine Lautenschläger; Steffen Hauptmann
Journal:  Virchows Arch       Date:  2004-09-16       Impact factor: 4.064

10.  Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.

Authors:  Suniti Misra; Vincent C Hascall; Carla De Giovanni; Roger R Markwald; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.